Andrew is ranked in Tier 1 for mid-market M&A by both Chambers UK and legal 500 directories as well as being listed as one of The Lawyer's Hot 100. Andrew's clients describe him as 'a strong negotiator and problem solver' as well as 'fast and pragmatic and able to understand our needs very well'.
He has particular expertise in the Life Sciences sector and is recognised within the legal directories as a 'very talented' corporate and commercial lawyer with a long-standing commitment to the biotechnology and pharmaceutical industries. Andrew has a wealth of expertise in Indian and Russian M&A, having acted on some of the largest multi-billion dollar transactions to have taken place in those jurisdictions.
Whilst at his previous firm, Andrew led the team on the contested public takeover of his long-standing client Lavendon Group plc, a transaction which garnered industry recognition at The Legal Business Awards.
|Since 2021||Partner, Taylor Wessing|
|2010 - 2021||Partner, Stephenson Harwood|
|2002 - 2010||Partner, Ashurst LLP|
|1994 - 2002||Associate, Ashurst Morris Crisp|
|1992 - 1994||Articled Clerk, Ashurst Morris Crisp|
|1994||Admitted as a lawyer, England and Wales|
|1987 - 1990||University of Birmingham, LLB Law|